Joshua Aaker, PhD
Senior DirectorAs a key member of Sg2’s Intelligence team, Josh leads cardiovascular thought leadership by analyzing the impact of emerging trends, technologies and clinical advancements on care delivery. In addition to his national perspective, Josh provides direct support to Sg2 members through custom intelligence and on-site engagements, helping organizations navigate complex challenges and uncover strategic growth opportunities in cardiovascular care.
Prior to joining Sg2, Josh received a PhD in neurobiology from the University of Chicago, where he studied the application of data analytics in understanding how oligodendrocytes function. In his graduate research, Josh leveraged genomics technologies to identify novel proteins involved in development to provide tools for the study of multiple sclerosis. He previously earned a BA in neurobiology from Macalester College and is a member of its local alumni association.
Josh has published his work in several international scientific journals and has also presented at numerous national and international conferences. In his spare time, he enjoys participating in his book club, learning to cook and traveling.
Prior to joining Sg2, Josh received a PhD in neurobiology from the University of Chicago, where he studied the application of data analytics in understanding how oligodendrocytes function. In his graduate research, Josh leveraged genomics technologies to identify novel proteins involved in development to provide tools for the study of multiple sclerosis. He previously earned a BA in neurobiology from Macalester College and is a member of its local alumni association.
Josh has published his work in several international scientific journals and has also presented at numerous national and international conferences. In his spare time, he enjoys participating in his book club, learning to cook and traveling.